BIOMAT Database Logo BIOMAT Database Logo

Effects of raclopride treatment on plasma and CSF HVA: relationships with clinical improvement in male schizophrenics. 1994

J G Csernansky, and J W Newcomer, and K Jackson, and L Lombrozo, and K F Faull, and R Zipursky, and A Pfefferbaum, and W O Faustman
Department of Psychiatry, Washington University School of Medicine, St. Louis, MO 63110.

Thirty-two acutely psychotic, male schizophrenic patients received raclopride, at 2, 6, or 12 mg/day, or haloperidol, 15 mg/day for 4 weeks after randomized, double-blind assignment. Twenty-six patients, including 19 who had been assigned one of the three doses of raclopride, completed the study. Raclopride, particularly at 12 mg/day, increased CSF homovanillic acid (HVA) at 4 weeks, and plasma HVA at 2 days, of treatment. The clinical response to raclopride was significantly correlated with plasma raclopride concentrations and baseline plasma HVA concentrations. Although raclopride is a substituted benzamide with atypical properties in animals, these results suggest that the doses of raclopride required for clinical efficacy and elevation of clinical indices of brain dopamine turnover are similar.

UI MeSH Term Description Entries
D008297 Male Males
D008734 Methoxyhydroxyphenylglycol Synthesized from endogenous epinephrine and norepinephrine in vivo. It is found in brain, blood, CSF, and urine, where its concentrations are used to measure catecholamine turnover. Hydroxymethoxyphenylglycol,MHPG,MOPEG,Vanylglycol,4-Hydroxy-3-methoxyphenylethylene Glycol,4-Hydroxy-3-methoxyphenylethyleneglycol,4-Hydroxy-3-methoxyphenylglycol,Methoxyhydroxyphenylglycol, (+)-Isomer,Methoxyhydroxyphenylglycol, (+-)-Isomer,Methoxyhydroxyphenylglycol, (-)-Isomer,4 Hydroxy 3 methoxyphenylethylene Glycol,4 Hydroxy 3 methoxyphenylethyleneglycol,4 Hydroxy 3 methoxyphenylglycol
D011569 Psychiatric Status Rating Scales Standardized procedures utilizing rating scales or interview schedules carried out by health personnel for evaluating the degree of mental illness. Factor Construct Rating Scales (FCRS),Katz Adjustment Scales,Lorr's Inpatient Multidimensional Psychiatric Rating Scale,Wittenborn Scales,Edinburgh Postnatal Depression Scale,Mini International Neuropsychiatric Interview
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D006719 Homovanillic Acid A 3-O-methyl ETHER of (3,4-dihydroxyphenyl)acetic acid. 3-Methoxy-4-Hydroxyphenylacetic Acid,4-Hydroxy-3-Methoxyphenylacetic Acid,3 Methoxy 4 Hydroxyphenylacetic Acid,4 Hydroxy 3 Methoxyphenylacetic Acid,Acid, 3-Methoxy-4-Hydroxyphenylacetic,Acid, 4-Hydroxy-3-Methoxyphenylacetic,Acid, Homovanillic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006897 Hydroxyindoleacetic Acid 5-HIAA,5-Hydroxy-3-Indoleacetic Acid,5-Hydroxyindolamine Acetic Acid,5 Hydroxy 3 Indoleacetic Acid,5 Hydroxyindolamine Acetic Acid,Acetic Acid, 5-Hydroxyindolamine,Acid, 5-Hydroxy-3-Indoleacetic,Acid, 5-Hydroxyindolamine Acetic,Acid, Hydroxyindoleacetic
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012457 Salicylamides Amides of salicylic acid.
D012559 Schizophrenia A severe emotional disorder of psychotic depth characteristically marked by a retreat from reality with delusion formation, HALLUCINATIONS, emotional disharmony, and regressive behavior. Dementia Praecox,Schizophrenic Disorders,Disorder, Schizophrenic,Disorders, Schizophrenic,Schizophrenias,Schizophrenic Disorder

Related Publications

J G Csernansky, and J W Newcomer, and K Jackson, and L Lombrozo, and K F Faull, and R Zipursky, and A Pfefferbaum, and W O Faustman
Effects of debrisoquin on CSF and plasma HVA concentrations in man.
June 1985, Life sciences,
J G Csernansky, and J W Newcomer, and K Jackson, and L Lombrozo, and K F Faull, and R Zipursky, and A Pfefferbaum, and W O Faustman
Plasma and CSF HVA before and after pharmacological treatment.
April 1989, Psychiatry research,
J G Csernansky, and J W Newcomer, and K Jackson, and L Lombrozo, and K F Faull, and R Zipursky, and A Pfefferbaum, and W O Faustman
Effect of trifluoperazine on CSF and plasma HVA levels in schizophrenic subjects.
November 1988, The American journal of psychiatry,
J G Csernansky, and J W Newcomer, and K Jackson, and L Lombrozo, and K F Faull, and R Zipursky, and A Pfefferbaum, and W O Faustman
Fluphenazine treatment reduces CSF somatostatin in patients with schizophrenia: correlations with CSF HVA.
February 1989, Biological psychiatry,
J G Csernansky, and J W Newcomer, and K Jackson, and L Lombrozo, and K F Faull, and R Zipursky, and A Pfefferbaum, and W O Faustman
Plasma and CSF HVA levels in panic patients with comorbid social phobia.
September 1994, Biological psychiatry,
J G Csernansky, and J W Newcomer, and K Jackson, and L Lombrozo, and K F Faull, and R Zipursky, and A Pfefferbaum, and W O Faustman
Effects of fenfluramine on plasma HVA in OCD.
May 1992, Psychiatry research,
J G Csernansky, and J W Newcomer, and K Jackson, and L Lombrozo, and K F Faull, and R Zipursky, and A Pfefferbaum, and W O Faustman
Plasma androgens in male schizophrenics.
December 1972, Archives of general psychiatry,
J G Csernansky, and J W Newcomer, and K Jackson, and L Lombrozo, and K F Faull, and R Zipursky, and A Pfefferbaum, and W O Faustman
Isoniazid effects on choreiform movement and on GABA, HVA, and 5-HIAA in CSF.
February 1983, Acta neurologica Scandinavica,
J G Csernansky, and J W Newcomer, and K Jackson, and L Lombrozo, and K F Faull, and R Zipursky, and A Pfefferbaum, and W O Faustman
Phenylethylamine and monoamine metabolites in CSF of schizophrenics: effects of neuroleptic treatment.
January 1983, Journal of neural transmission,
J G Csernansky, and J W Newcomer, and K Jackson, and L Lombrozo, and K F Faull, and R Zipursky, and A Pfefferbaum, and W O Faustman
[Effects of blood, CSF & urine of schizophrenics on Protozoa].
January 1958, Wiener Zeitschrift fur Nervenheilkunde und deren Grenzgebiete,
Copied contents to your clipboard!